Evidence map›Paper›PMID 41451217›Full record

ArticleFrontiers in immunology2025

A 41-marker 37-color full spectrum flow cytometry panel for the deep immunophenotyping of human peripheral and liver natural killer cells.

Alberta Gerarda Antonia Paul, Konrad H H Reichel, Juan J Garcia-Vallejo, Lara R Heij, Maria C Jaimes, Yacine Kharraz

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alberta Gerarda Antonia PaulScientific Commercialization Team (SCT), Cytek Biosciences Inc, Fremont, CA, United States.
Konrad H H ReichelDepartment of Molecular Cell Biology and Immunology (MCBI), Amsterdam Infection and Immunity and Cancer Center Amsterdam, Amsterdam University Medical Centers, Free University of Amsterdam, Amsterdam, Netherlands.
Juan J Garcia-VallejoDepartment of Molecular Cell Biology and Immunology (MCBI), Amsterdam Infection and Immunity and Cancer Center Amsterdam, Amsterdam University Medical Centers, Free University of Amsterdam, Amsterdam, Netherlands.
Lara R HeijDepartment of General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany.
Maria C JaimesScientific Commercialization Team (SCT), Cytek Biosciences Inc, Fremont, CA, United States.
Yacine KharrazScientific Commercialization Team (SCT), Cytek Biosciences Inc, Fremont, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer cells (NK cells) are granular lymphocytes with cytotoxic activity that have a role in both innate and adaptive immune responses. NK cells consist of a diverse array of phenotypes with specific functions imposed by the microenvironment. Liver NK cells are an abundant lymphocyte population playing a key role in tuning immune responses under physiological and pathological conditions. For example, NK cell functional and phenotypic changes occur during liver cancer progression and correlate with disease prognosis. As liver cancer has the second-highest mortality rate among solid cancers, it is important to define the composition and the dynamics of the liver and peripheral NK cell compartment both in health and disease state. In-depth analysis of the phenotypes and functional status of NK cells and their frequencies will expand our knowledge on their role in maintaining immune tolerance, disease progression, and aid the development of novel treatments. We present here a 41-marker 37-color spectral flow cytometry panel for the in-depth phenotyping of human peripheral and liver NK cells. This paper describes the first spectral flow cytometry panel with 35 markers potentially co-expressed on one cell type (NK cells) including the panel design process, sample preparation, staining protocol, quality control metrics, acquisition protocol and workflows to analyze NK cells in the periphery and liver. NK cell subsets and phenotypes were distinguished by including markers of differentiation, maturation, tissue residency, migratory potential, functional status, key transcription factors, and immune checkpoint molecules. Liver-type ILC1s (Lt-ILC1s) could be identified by inclusion of additional markers and modification of published gating strategies. Furthermore, we describe the dynamics of peripheral and liver NK cells. Finally, we show the validity of markers included to indicate NK cell dysfunction in samples of patients with Hepatocellular Carcinoma (HCC). This high parameter high resolution panel provides a key tool for in-depth delineation of distinct NK cell subsets in the periphery and in liver, in health and disease state. It allows for the robust identification of NK cells subsets with low frequencies and can effectively be used for samples with limited cell numbers.

Indexed as

Flow CytometryImmunophenotypingKiller Cells, NaturalLiverBiomarkersHumansLiver NeoplasmsPhenotypeBiomarkersAuroracancerflow cytometryhigh dimensionalhuman NK cellliverPBMCsspectral

Identifiers

PMID41451217
PMCPMC12728072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.